Related references
Note: Only part of the references are listed.Stromal categorization in early oral tongue cancer
Alhadi Almangush et al.
VIRCHOWS ARCHIV (2021)
Biopsy quality is essential for preoperative prognostication in oral tongue cancer
Ibrahim O. Bello et al.
APMIS (2021)
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H. Strickler et al.
CLINICAL CANCER RESEARCH (2021)
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
Kenneth Emancipator et al.
MODERN PATHOLOGY (2021)
Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection
Chen Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma A Study of 1034 Patients
Talia L. Fuchs et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice
Alhadi Almangush et al.
ACTA OTO-LARYNGOLOGICA (2020)
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
Matthew P. Humphries et al.
BMC CANCER (2020)
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
Dovile Zilenaite et al.
FRONTIERS IN ONCOLOGY (2020)
A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
Inger-Heidi Bjerkli et al.
VIRCHOWS ARCHIV (2020)
Digital Image Analysis of CD8+and CD3+Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma
Yenlin Huang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D. Schoenfeld et al.
JAMA ONCOLOGY (2020)
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha et al.
CANCER DISCOVERY (2020)
A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
Youchao Xiao et al.
FRONTIERS IN ONCOLOGY (2020)
The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
Franck Pages et al.
ONCOIMMUNOLOGY (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis
Elin Hadler-Olsen et al.
BRITISH JOURNAL OF CANCER (2019)
Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
Chungsu Hwang et al.
ONCOLOGY LETTERS (2019)
The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis
Zhengxian Huang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Evaluating the prognostic significance of tumor-infiltrating lymphocytes in solid tumor: practice of a standardized method from the International Immuno-Oncology Biomarkers Working Group
Jiu-Yang Liu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma
Muhammad Shaban et al.
SCIENTIFIC REPORTS (2019)
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M. Oliva et al.
ANNALS OF ONCOLOGY (2019)
Immune checkpoint inhibitors win the 2018 Nobel Prize
Pei-Wei Huang et al.
BIOMEDICAL JOURNAL (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
Dan P. Zandberg et al.
EUROPEAN JOURNAL OF CANCER (2019)
Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours
Nina Linder et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The prognostic value of immune checkpoints in oral squamous cell carcinoma
Meri Sievilainen et al.
ORAL DISEASES (2019)
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology
Nicolas A. Giraldo et al.
VIRCHOWS ARCHIV (2019)
Immunotherapy for head and neck cancer: Recent advances and future directions
John D. Cramer et al.
ORAL ONCOLOGY (2019)
Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma
J. M. Moskovitz et al.
JOURNAL OF DENTAL RESEARCH (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
A history of exploring cancer in context
Shelly Maman et al.
NATURE REVIEWS CANCER (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Prognostic biomarkers in oral squamous cell carcinoma: A systematic review
Cesar Rivera et al.
ORAL ONCOLOGY (2017)
Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis
Alhadi Almangush et al.
BRITISH JOURNAL OF CANCER (2017)
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
Edwin R. Parra et al.
CLINICAL CANCER RESEARCH (2016)
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma
Marlon C. Rebelatto et al.
DIAGNOSTIC PATHOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Share Paper
